| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/24/1993 | EP0528587A1 Inhibiting osteoclast-mediated bone resorption using substituted phenyl derivatives |
| 02/24/1993 | EP0528586A1 Inhibiting osteoclast-mediated bone resorption using aminoalkyl-substituted phenyl derivatives |
| 02/24/1993 | EP0528515A2 HMG-CoA reductase inhibitors in the prevention of restenosis following coronary angioplasty |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0527802A1 Ligand for the neu gene product. |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/23/1993 | US5189149 High concentration, solvent-free |
| 02/23/1993 | US5189049 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | US5189043 Isoquinolone derivatives, their production and use |
| 02/23/1993 | US5189031 Urea derivatives, compositions and use |
| 02/23/1993 | CA1313872C Acetamide derivatives of dihydro-2,3-phenyl-3 -benzofuran-2-one, processes for their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | CA1313871C Derivatives of (dihydro-2,3-oxo-2-benzofuranyl-3)-2- acetic acid, processes for their preparation and pharmaceutical compositions containing them |
| 02/21/1993 | CA2076444A1 2,4-thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing same |
| 02/18/1993 | WO1993002737A1 Treatment for type ii diabetes |
| 02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | WO1993002678A1 Use of quinozilinederivatives as orexigenics |
| 02/18/1993 | WO1992022299A3 Use of antiarrhythmic agents to lower cholesterol |
| 02/18/1993 | CA2114797A1 Treatment for type ii diabetes |
| 02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
| 02/17/1993 | EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use |
| 02/17/1993 | EP0527458A1 New 3,5-di-tert.-butyl-4-hydroxyphenyl derivatives, process for their preparation and pharmaceutical compounds |
| 02/17/1993 | EP0527232A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 02/17/1993 | CN1069024A Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for preparation thereof |
| 02/17/1993 | CN1069023A 4-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/17/1993 | CN1069022A 4-(2-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/17/1993 | CN1019911C Benzoxazine derivative and processes for preparing same |
| 02/16/1993 | US5187190 Treatment of obesity |
| 02/16/1993 | US5187168 Substituted quinazolines as angiotensin II antagonists |
| 02/10/1993 | EP0527081A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use |
| 02/10/1993 | EP0526936A2 Cholesterol-lowering agents |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526658A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 02/10/1993 | EP0526495A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
| 02/10/1993 | CN1068825A Tetrahydropyrrolo (1,2-a) pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for preparation thereof and pharmaceutical compositions containing same |
| 02/10/1993 | CN1068823A Hypoglycemic thiazolidinediones and intermediates |
| 02/10/1993 | CN1068820A (s)(+)-2-ethoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof |
| 02/10/1993 | CN1068817A Indole derivatives |
| 02/10/1993 | CN1068816A Indoles |
| 02/10/1993 | CA2088518A1 Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| 02/10/1993 | CA2075612A1 Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| 02/09/1993 | US5185452 Antidiabetic agents; aldose reductase inhibitor |
| 02/09/1993 | CA2075459A1 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors |
| 02/04/1993 | WO1993003714A2 Method for treatment of metabolic disorders |
| 02/04/1993 | WO1993002185A1 Acat inhibitor |
| 02/04/1993 | WO1993002079A1 Hypoglycemic thiazolidinediones and intermediates |
| 02/04/1993 | WO1993002061A1 Chiral intermediates for the preparation of antidiabetics thiazoles |
| 02/04/1993 | WO1993002051A1 Indoles |
| 02/04/1993 | WO1993002050A1 Indoles |
| 02/04/1993 | WO1993002048A1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 02/04/1993 | WO1993001829A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 02/04/1993 | CA2114140A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 02/04/1993 | CA2113817A1 A method for treatment of metabolic disorders |
| 02/04/1993 | CA2112689A1 Indoles |
| 02/04/1993 | CA2112678A1 Indoles |
| 02/03/1993 | EP0526402A1 Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
| 02/03/1993 | EP0526200A1 2-(Imidazol-1-YL)-2-benzyl-ethylidene-aminoxyalkanoic acid derivatives as thromboxane A2 inhibitors |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0525938A1 Gallium compounds |
| 02/03/1993 | EP0525846A1 Sporomiella intermedia and processes therefrom |
| 02/03/1993 | EP0525537A1 Use of 1,4-dihydropyridine derivatives for the preparation of a medicament for the treatment of neuropathies caused by diabetes mellitus |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525388A1 Suckable or chewable tablet |
| 02/03/1993 | EP0525167A1 Sustained drug release through topical application of bioadhesive liposomes. |
| 02/03/1993 | EP0525158A1 Hyperglycemic compositions |
| 02/03/1993 | EP0525002A1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/03/1993 | CA2074999A1 Cholesterol-lowering compounds |
| 02/02/1993 | US5183823 Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
| 02/02/1993 | US5183674 Food and feedstuff |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074846A1 "2-(imidazol-1-yl)-2-benzylethylidene-aminoxyalkanoic acid derivatives" |
| 01/31/1993 | CA2074797A1 Certain heteroaryl substituted hydroxylamine derivatives |
| 01/31/1993 | CA2074709A1 Use of 1,4-dihydropyridines in diabetes |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524595A1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 01/27/1993 | EP0524190A1 Hmg-co a reductive inhibitors |
| 01/27/1993 | EP0387328B1 Glyceride containing nutrient for human and animals |
| 01/26/1993 | CA1313139C D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione as an anti-atherosclerosis agent |
| 01/26/1993 | CA1313135C Cholestyramine composition and process for its preparation |
| 01/26/1993 | CA1313134C Endogenous growth hormone |
| 01/21/1993 | WO1993001165A2 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000915A1 Colestipol hydrochloride high-content tablets |
| 01/21/1993 | DE4222647A1 Peptid-zubereitungen Peptide preparations |
| 01/21/1993 | CA2110725A1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/20/1993 | EP0524023A1 Trifluoromethylbenzylphosphonates useful in treating osteoporosis |
| 01/20/1993 | EP0524004A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives |
| 01/20/1993 | EP0523086A1 Pharmaceutical aqueous solution of 4- 2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
| 01/20/1993 | CN1068111A Derivatives of (hetero) aromatic ethers and thioethers process for preparing same and pharmaceutical composition containing them |
| 01/19/1993 | US5180742 Lipoxygenase Inhibitors |
| 01/19/1993 | US5180739 Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases |
| 01/19/1993 | US5180588 Dioxabicyclo 3.3.0!octane derivatives and enzyme transferases |
| 01/19/1993 | CA2074020A1 Trifluormethylbenzylphosphonates useful in treating osteoporosis |
| 01/18/1993 | CA2074038A1 Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives |
| 01/13/1993 | EP0522715A1 Squalene synthethase inhibitors and processes therefrom |
| 01/13/1993 | EP0522599A1 New method for the isolation of castanospermine |
| 01/13/1993 | EP0522576A2 Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use |
| 01/13/1993 | EP0522502A1 Inhibitors of sucrase activity from tea |
| 01/13/1993 | EP0522080A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |